Source: Annual Congress 2003 - Staging and outcome in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Wakabayashi, H. Katsura, K. Yamada, T. Motegi, M. Omata, N. Nishimura, R. Goto, K. Kida (Tokyo, Japan). Relation of various parameters to the survival rate in stage 0 to stage IIa chronic obstructive pulmonary disease (COPD) according to the GOLD guidelines. Eur Respir J 2003; 22: Suppl. 45, 3630

Member's Comments

No comment yet.

Related content which might interest you: Impact of comorbidities on survival of patients with COPD according to GOLD stages Source: Annual Congress 2011 - COPD: burden of disease, imaging and management Year: 2011 COPD GOLD stage 1: Is it really a disease? Source: Annual Congress 2011 - COPD mechanisms Year: 2011 GOLD stage 0 and risk of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 352s Year: 2003 Lung volume response to bronchodilators is dependent on the stage of the disease in chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2006 - COPD therapy Year: 2006 Relationship between maximal exercise capacity and activities of daily living in patients with GOLD stage II-III chronic obstructive pulmonary disease Source: International Congress 2018 – Chronic respiratory disease : determinants of physical activity in patients Year: 2018 Model of staged development chronic obstructive pulmonary disease (COPD) in rats Source: Annual Congress 2011 - Novel mechanisms in lung injury Year: 2011 Does Nutritional Risk Screening 2002 correlate with  dyspnea status of patients with GOLD stage 3-4 chronic obstructive pulmonary disease: a Cohort study. Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD Year: 2018 Renewed role of nitrogen slope of phase III in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II Year: 2008 Chronic obstructive pulmonary disease in 55 years old women from Germany according to GOLD stages Source: Eur Respir J 2004; 24: Suppl. 48, 359s Year: 2004 Socioeconomic status shaping GOLD A-D classification in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Relevance of pulmonary hypertension (PH) in COPD: prevalence of resting and exercise-induced PH at different GOLD stages Source: Annual Congress 2007 - Pulmonary vascular involvement in smoking and respiratory diseases Year: 2007 Evaluation of adequacy of pharmacological treatment in relation to severity in patients with chronic obstructive pulmonary disease (COPD) and their clinical correlations. Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 Stage 0 in GOLD does not predict future clinical COPD Source: Eur Respir J 2002; 20: Suppl. 38, 401s Year: 2002 Does health status predict survival in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 203s Year: 2002 Comparison between predicted death rates by APACHE II and MPMo scores in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 83s Year: 2002 Chronic obstructive pulmonary disease assessment test (CAT) in patients with COPD, chronic heart failure (CHF), and both Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Effect of COPD severity on hemodynamic responses to exercise in patients with GOLD stages I-IV Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation Year: 2011 The audit-intervention-reaudit cycle can improve diagnostic standards for chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - COPD exacerbation Year: 2010 Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging: a pooled analysis of individual patient data Source: ERJ Open Res, 6 (4) 00253-2020; 10.1183/23120541.00253-2020 Year: 2020